On May 19, 2015, the Board of Directors of Verde Science, Inc. elected David Alexander to be the Chief Financial Officer of the company. Mr. Alexander managed the rapid growth of several early stage startup companies. As CFO of the start-up Nortran Pharmaceuticals, Inc. he assisted in obtaining its initial financing and first discoveries.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2021 | Verde Science : Two more UK energy suppliers stop trading on gas price hit | RE |
2018 | Verde Science, Inc. Announces Executive Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 23 | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.05% | 22.15B | |
-17.37% | 21.02B | |
-8.28% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VRCI Stock
- News Verde Science, Inc.
- Verde Science, Inc. Appoints David Alexander as Chief Financial Officer